Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-01

Clinical Trial Update: Simvastatin in Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin in people with secondary progressive multiple sclerosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University College, London | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-01